Buffalo Grove, Illinois-based Angus manufactures and distributes nitroalkanes and their derivatives, which are used as additives and intermediates for products in industries such as metalworking, oil and gas, water treatment and paints and coatings. Examples of its products include a variety of primary amino alcohols and corrosion inhibitors marketed under the Corrguard brand and AEPD-85 primary amino alcohols designed for use in water-dilutable metalworking fluids.  

Angus produces amino methyl propanol in two manufacturing facilities – one in Sterlington, Louisiana, and the other in Ibbenburen, Germany.

The companies said Ardian and Golden Gate Capital will partner with Angus President and CEO David Neuberger and the company’s current senior management team to grow the business through continued focus on and investment in core markets supplemented by development of application adjacencies and of new-to-world molecules.

“With Ardian’s global reach and together with Golden Gate Capital, we plan to accelerate the company’s growth and provide Angus’ customers with a compelling range of products,” Thibault Basquin, head of Americas investments at Ardian Buyout, stated in an Oct. 13 news release. “We have deep expertise and an extensive network in the sectors served by Angus, and we intend to support the company in the implementation of a global buy and build strategy, similar to our approach with other successful investments.”

Ardian describes itself as a world-leading private investment house that is majority owned by its employees. The company manages or advises $100 billion in investments across Europe, the Americas, Asia and the Middle East on behalf of governments, institutions, pension funds and high net-worth investors. Golden Gate Capital is a private equity investment firm with over $17 billion of committed capital.